Navigate this market better. Subscribe for FREE stock alerts and information.

Friday, July 11, 2014

Nordion's deal with Sterigenics clears U.S. antitrust hurdle, (TSE: NDN.TO), (NYSE: NDZ)

Nordion Inc , a Canadian supplier of medical isotopes, said it had cleared a U.S. antitrust hurdle, paving the way for the company to be acquired by Sterigenics. The U.S. Federal Trade Commission terminated the waiting period for the acquisition under the Hart-Scott-Rodino Antitrust Improvements Act, Nordion said in a statement.The company said in June it had received a request for additional information from the U.S. regulator.Nordion also said on Friday that it received a no-action letter from the Canadian Competition Bureau.The deal is expected to close in the second half of this year.

Nordion Inc. (Nordion) is a global health science company, engaged providing products and services used for the prevention, diagnosis and treatment of disease. Shares of NDN fell by 0.38% or $-0.05/share to $13.26. In the past year, the shares have traded as low as $7.40 and as high as $14.27. On average, 51166 shares of NDN.TO exchange hands on a given day and today's volume is recorded at 8786.

Nordion Inc. (Nordion) is a global health science company, engaged providing products and services used for the prevention, diagnosis and treatment of disease. Shares of NDZ fell by 0.24% or $-0.03/share to $12.45. In the past year, the shares have traded as low as $7.22 and as high as $12.98. On average, 714402 shares of NDZ exchange hands on a given day and today's volume is recorded at 322081.



Source